P68 RNA helicase as a molecular target for cancer therapy

Journal of Experimental and Clinical Cancer Research

Volumn 33, Issue 1, 2014, Pages

  Dai, Ting Yu ^a   Cao, Liu ^a   Yang, Zi Chen ^a   Li, Ya Shu ^a   Tan, Li ^a   Ran, Xin Ze ^a   Shi, Chun Meng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Molecular target; P68; Rna helicase; Transcriptional co activator

Indexed keywords

ANDROGEN RECEPTOR; BETA CATENIN; ESTROGEN RECEPTOR ALPHA; PROTEIN P53; PROTEIN P68; RNA HELICASE; ANTINEOPLASTIC AGENT; DEAD BOX PROTEIN; ENZYME INHIBITOR;

BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CANCER THERAPY; CARCINOGENESIS; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME STRUCTURE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PATHOLOGY; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DEAD-BOX RNA HELICASES; DRUG DESIGN; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, MOLECULAR; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84965191065     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/s13046-014-0064-y     Document Type: Review

References (96)

1. Fuller-Pace FV: RNA helicases: modulators of RNA structure. Trends Cell Biol 1994, 4:271-274.
2. Schmid SR, Linder P: D-E-A-D protein family of putative RNA helicases. Mol Microbiol 1992, 6:283-291.
3. Lane DP, Hoeffler WK: SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000. Nature 1980, 288:167-170.
4. Iggo RD, Lane DP: Nuclear protein p68 is an RNA-dependent ATPase. EMBO J 1989, 8:1827-1831.
5. Fuller-Pace FV: DEAD box RNA helicase functions in cancer. RNA Biol 2013, 10:121-132.
6. Ogilvie VC, Wilson BJ, Nicol SM, Morrice NA, Saunders LR, Barber GN, Fuller-Pace FV: The highly related DEAD box RNA helicases p68 and p72 exist as heterodimers in cells. Nucleic Acids Res 2003, 31:1470-1480.
7. Endoh H, Maruyama K, Masuhiro Y, Kobayashi Y, Goto M, Tai H, Yanagisawa J, Metzger D, Hashimoto S, Kato S: Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol Cell Biol 1999, 19:5363-5372.
8. Caretti G, Schiltz RL, Dilworth FJ, Di Padova M, Zhao P, Ogryzko V, Fuller-Pace FV, Hoffman EP, Tapscott SJ, Sartorelli V: The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. Dev Cell 2006, 11:547-560.
9. Jensen ED, Niu L, Caretti G, Nicol SM, Teplyuk N, Stein GS, Sartorelli V, van Wijnen AJ, Fuller-Pace FV, Westendorf JJ: p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation. JCellBiochem2008, 103:1438-1451.
10. Clark EL, Coulson A, Dalgliesh C, Rajan P, Nicol SM, Fleming S, Heer R, Gaughan L, Leung HY, Elliott DJ, Fuller-Pace FV, Robson CN: The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res 2008, 68:7938-7946.
11. Bates GJ, Nicol SM, Wilson BJ, Jacobs AM, Bourdon JC, Wardrop J, Gregory DJ, LaneDP,PerkinsND,Fuller-PaceFV:The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor. EMBO J 2005, 24:543-553.
12. Fuller-Pace FV, Moore HC: RNA helicases p68 and p72: multifunctional proteins with important implications for cancer development. Future Oncol 2011, 7:239-251.
13. Linder P, Fuller-Pace F: Looking back on the birth of DEAD-box RNA helicases. Biochim Biophys Acta 2013, 8:750-755.
14. Mallam AL, Del Campo M, Gilman B, Sidote DJ, Lambowitz AM: Structural basis for RNA-duplex recognition and unwinding by the DEAD-box helicase Mss116p. Nature 2012, 490:121-125.
15. Andreou AZ, Klostermeier D: Conformational changes of DEAD-box helicases monitored by single molecule fluorescence resonance energy transfer. Methods Enzymol 2012, 511:75-109.
16. Tanner NK, Cordin O, Banroques J, Doere M, Linder P: The Q motif: a newly identified motif in DEAD box helicases may regulate ATP binding and hydrolysis. Molecular cell 2003, 11:127-138.
17. Cordin O, Tanner NK, Doere M, Linder P, Banroques J: The newly discovered Q motif of DEAD-box RNA helicases regulates RNA-binding and helicase activity. The EMBO journal 2004, 23:2478-2487.
18. Banroques J, Doere M, Dreyfus M, Linder P, Tanner NK: Motif III in superfamily 2 "helicases" helps convert the binding energy of ATP into a high-affinity RNA binding site in the yeast DEAD-box protein Ded1. J Mol Biol 2010, 396:949-966.
19. Banroques J, Cordin O, Doere M, Linder P, Tanner NK: A conserved phenylalanine of motif IV in superfamily 2 helicases is required for cooperative, ATP-dependent binding of RNA substrates in DEAD-box proteins. Mol Cell Biol 2008, 28:3359-3371.
20. Jankowsky E: RNA helicases at work: binding and rearranging. Trends Biochem Sci 2011, 36:19-29.
21. Hirling H, Scheffner M, Restle T, Stahl H: RNA helicase activity associated with the human p68 protein. Nature 1989, 339:562-564.
22. Hamm J, Lamond AI: Spliceosome assembly: the unwinding role of DEAD-box proteins. Curr Biol 1998, 8:R532-R534.
23. Liu ZR: p68 RNA helicase is an essential human splicing factor that acts at the U1 snRNA-5' splice site duplex. Mol Cell Biol 2002, 22:5443-5450.
24. Lin C, Yang L, Yang JJ, Huang Y, Liu ZR: ATPase/helicase activities of p68 RNA helicase are required for pre-mRNA splicing but not for assembly of the spliceosome. Mol Cell Biol 2005, 25:7484-7493.
25. Kar A, Fushimi K, Zhou X, Ray P, Shi C, Chen X, Liu Z, Chen S, Wu JY: RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site. Mol Cell Biol 2011, 31:1812-1821.
26. Guil S, Gattoni R, Carrascal M, Abian J, Stevenin J, Bach-Elias M: Roles of hnRNP A1, SR proteins, and p68 helicase in c-H-ras alternative splicing regulation. Mol Cell Biol 2003, 23:2927-2941.
27. Ma R, Jiang T, Kang X: Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res 2012, 31:38.
28. Zeng Y, Yi R, Cullen BR: Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha. EMBO J 2005, 24:138-148.
29. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R: The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
30. Fukuda T, Yamagata K, Fujiyama S, Matsumoto T, Koshida I, Yoshimura K, Mihara M, Naitou M, Endoh H, Nakamura T, Akimoto C, Yamamoto Y, Katagiri T, Foulds C, Takezawa S, Kitagawa H, Takeyama K, O'Malley BW, Kato S: DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat Cell Biol 2007, 9:604-611.
31. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K: Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
32. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A: Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 2010, 39:373-384.
33. Bond AT, Mangus DA, He F, Jacobson A: Absence of Dbp2p alters both nonsense-mediated mRNA decay and rRNA processing. Mol Cell Biol 2001, 21:7366-7379.
34. Jalal C, Uhlmann-Schiffler H, Stahl H: Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation. Nucleic Acids Res 2007, 35:3590-3601.
35. Maggi LB Jr, Kuchenruether M, Dadey DY, Schwope RM, Grisendi S, Townsend RR, Pandolfi PP, Weber JD: Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome. Mol Cell Biol 2008, 28:7050-7065.
36. Bertwistle D, Sugimoto M, Sherr CJ: Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 2004, 24:985-996.
37. Saporita AJ, Chang HC, Winkeler CL, Apicelli AJ, Kladney RD, Wang J, Townsend RR, Michel LS, Weber JD: RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis. Cancer Res 2011, 71:6708-6717.
38. Kitamura A, Nishizuka M, Tominaga K, Tsuchiya T, Nishihara T, Imagawa M: Expression of p68 RNA helicase is closely related to the early stage of adipocyte differentiation of mouse 3 T3-L1 cells. Biochem Biophys Res Commun 2001, 287:435-439.
39. Kircher SG, Kim SH, Fountoulakis M, Lubec G: Reduced levels of DEAD-box proteins DBP-RB and p72 in fetal Down syndrome brains. Neurochem Res 2002, 27:1141-1146.
40. Meola G, Jones K, Wei C, Timchenko LT: Dysfunction of protein homeostasis in myotonic dystrophies. Histol Histopathol 2013,
41. Singh C, Haines GK, Talamonti MS, Radosevich JA: Expression of p68 in human colon cancer. Tumour Biol 1995, 16:281-289.
42. Haines GK, Cajulis R, Hayden R, Duda R, Talamonti M, Radosevich JA: Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. Tumour Biol 1996, 17:5-12.
43. Dosaka-Akita H, Harada M, Miyamoto H, Kawakami Y: [Clinical significance of oncogene product expression in human lung cancer]. Nihon Kyobu Shikkan Gakkai Zasshi 1992, 30:1441-1447.
44. Wang SJ, Zhang C, You Y, Shi CM: Overexpression of RNA helicase p68 protein in cutaneous squamous cell carcinoma. Clin Exp Dermatol 2012, 37:882-888.
45. Lin S, Tian L, Shen H, Gu Y, Li JL, Chen Z, Sun X, James You M, Wu L: DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia. Oncogene 2012,
46. Shin S, Rossow KL, Grande JP, Janknecht R: Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res 2007, 67:7572-7578.
47. Causevic M, Hislop RG, Kernohan NM, Carey FA, Kay RA, Steele RJ, Fuller-Pace FV: Overexpression and poly-ubiquitylation of the DEADbox RNA helicase p68 in colorectal tumours. Oncogene 2001, 20:7734-7743.
48. Wang D, Huang J, Hu Z: RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells. Mol Cell Proteomics 2012, 11:M111 011932.
49. Fujita T, Kobayashi Y, Wada O, Tateishi Y, Kitada L, Yamamoto Y, Takashima H, Murayama A, Yano T, Baba T, Kato S, Kawabe Y, Yanagisawa J: Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells. JBiolChem2003, 278:26704-26714.
50. Beier UH, Maune S, Meyer JE, Gorogh T: Overexpression of p68 mRNA in head and neck squamous cell carcinoma cells. Anticancer Res 2006, 26:1941-1946.
51. Zhang X, Cairns M, Rose B, O'Brien C, Shannon K, Clark J, Gamble J, Tran N: Alterations in miRNA processing and expression in pleomorphic adenomas of the salivary gland. Int J Cancer 2009, 124:2855-2863.
52. Wang R, Jiao Z, Li R, Yue H, Chen L: p68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-kappaB transcription factor p50. Neuro Oncol 2012, 14:1116-1124.
53. Kitagawa N, Ojima H, Shirakihara T, Shimizu H, Kokubu A, Urushidate T, Totoki Y, Kosuge T, Miyagawa S, Shibata T: Downregulation of the microRNA biogenesis components and its association with poor prognosis in hepatocellular carcinoma. Cancer Sci 2013, 104:543-551.
54. Mooney SM, Grande JP, Salisbury JL, Janknecht R: Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential. Biochemistry 2010, 49:1-10.
55. Nicol SM, Fuller-Pace FV: Analysis of the RNA helicase p68 (Ddx5) as a transcriptional regulator. Methods Mol Biol 2010, 587:265-279.
56. Sambasivan R, Cheedipudi S, Pasupuleti N, Saleh A, Pavlath GK, Dhawan J: The small chromatin-binding protein p8 coordinates the association of anti-proliferative and pro-myogenic proteins at the myogenin promoter. J Cell Sci 2009, 122:3481-3491.
57. Wilson BJ, Bates GJ, Nicol SM, Gregory DJ, Perkins ND, Fuller-Pace FV: The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner. BMC Mol Biol 2004, 5:11.
58. Jiang Z, Guo J, Shen J, Jin M, Xie S, Wang L: The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells. J Exp Clin Cancer Res 2012, 31:42.
59. Watanabe M, Yanagisawa J, Kitagawa H, Takeyama K, Ogawa S, Arao Y, Suzawa M, Kobayashi Y, Yano T, Yoshikawa H, Masuhiro Y, Kato S: A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J 2001, 20:1341-1352.
60. Wortham NC, Ahamed E, Nicol SM, Thomas RS, Periyasamy M, Jiang J, Ochocka AM, Shousha S, Huson L, Bray SE, Coombes RC, Ali S, Fuller-Pace FV: The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer. Oncogene 2009, 28:4053-4064.
61. Wagner M, Rid R, Maier CJ, Maier RH, Laimer M, Hintner H, Bauer JW, Onder K: DDX5 is a multifunctional co-activator of steroid hormone receptors. Mol Cell Endocrinol 2012, 361:80-91.
62. Clark EL, Hadjimichael C, Temperley R, Barnard A, Fuller-Pace FV, Robson CN: p68/DdX5 supports beta-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer. PLoS One 2013, 8:e54150.
63. Jahn SC, Law ME, Corsino PE, Rowe TC, Davis BJ, Law BK: Assembly, Activation, and Substrate Specificity of Cyclin D1/Cdk2 Complexes. Biochemistry 2013, 52:3489-3501.
64. Cosgrove RA, Philpott A: Cell cycling and differentiation do not require the retinoblastoma protein during early Xenopus development. Dev Biol 2007, 303:311-324.
65. Meijer M, Murray JAH: The role and regulation of D-type cyclins in the plant cell cycle. Plant Mol Biol 2000, 43:621-633.
66. Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, Saville MK, Lane DP: p53 isoforms can regulate p53 transcriptional activity. Genes Dev 2005, 19:2122-2137.
67. Moore HC, Jordan LB, Bray SE, Baker L, Quinlan PR, Purdie CA, Thompson AM, Bourdon JC, Fuller-Pace FV: The RNA helicase p68 modulates expression and function of the Delta133 isoform(s) of p53, and is inversely associated with Delta133p53 expression in breast cancer. Oncogene 2010, 29:6475-6484.
68. Nicol SM, Bray SE, Black HD, Lorimore SA, Wright EG, Lane DP, Meek DW, Coates PJ, Fuller-Pace FV: The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage. Oncogene 2013, 32:3461-3469.
69. Yang L, Lin C, Zhao S, Wang H, Liu ZR: Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by upregulating cyclin D1 and c-Myc expression. JBiolChem2007, 282:16811-16819.
70. Chen HJ, Hsu LS, Shia YT, Lin MW, Lin CM: The beta-catenin/TCF complex as a novel target of resveratrol in the Wnt/beta-catenin signaling pathway. Biochem Pharmacol 2012, 84:1143-1153.
71. Arun G, Akhade VS, Donakonda S, Rao MR: mrhl RNA, a long noncoding RNA, negatively regulates Wnt signaling through its protein partner Ddx5/p68 in mouse spermatogonial cells. Mol Cell Biol 2012, 32:3140-3152.
72. Iqbal S, Zhang S, Driss A, Liu ZR, Kim HR, Wang Y, Ritenour C, Zhau HE, Kucuk O, Chung LW, Wu D: PDGF upregulates Mcl-1 through activation of beta-catenin and HIF-1alpha-dependent signaling in human prostate cancer cells. PLoS One 2012, 7:e30764.
73. Takaoka Y, Shimizu Y, Hasegawa H, Ouchi Y, Qiao S, Nagahara M, Ichihara M, Lee JD, Adachi K, Hamaguchi M, Iwamoto T: Forced expression of miR-143 represses ERK5/c-Myc and p68/p72 signaling in concert with miR-145 in gut tumors of Apc(Min) mice. PLoS One 2012, 7:e42137.
74. Davis BN, Hilyard AC, Lagna G, Hata A: SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
75. Xu J, Lamouille S, Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res 2009, 19:156-172.
76. Fuxe J, Vincent T, Garcia de Herreros A: Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle 2010, 9:2363-2374.
77. Kim Y, Kugler MC, Wei Y, Kim KK, Li X, Brumwell AN, Chapman HA: Integrin alpha3beta1-dependent beta-catenin phosphorylation links epithelial Smad signaling to cell contacts. J Cell Biol 2009, 184:309-322.
78. Kim KK, Wei Y, Szekeres C, Kugler MC, Wolters PJ, Hill ML, Frank JA, Brumwell AN, Wheeler SE, Kreidberg JA, Chapman HA: Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. JClinInvest2009, 119:213-224.
79. Buelt MK, Glidden BJ, Storm DR: Regulation of p68 RNA helicase by calmodulin and protein kinase C. J Biol Chem 1994, 269:29367-29370.
80. Yang L, Yang J, Huang Y, Liu ZR: Phosphorylation of p68 RNA helicase regulates RNA binding by the C-terminal domain of the protein. Biochem Biophys Res Commun 2004, 314:622-630.
81. Ford MJ, Anton IA, Lane DP: Nuclear protein with sequence homology to translation initiation factor eIF-4A. Nature 1988, 332:736-738.
82. Yang L, Lin C, Liu ZR: Signaling to the DEAD box-regulation of DEAD-box p68 RNA helicase by protein phosphorylations. Cell Signal 2005, 17:1495-1504.
83. Mooney SM, Goel A, D'Assoro AB, Salisbury JL, Janknecht R: Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase. J Biol Chem 2010, 285:30443-30452.
84. Jacobs AM, Nicol SM, Hislop RG, Jaffray EG, Hay RT, Fuller-Pace FV: SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1. Oncogene 2007, 26:5866-5876.
85. Yang L, Lin C, Liu ZR: P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin. Cell 2006, 127:139-155.
86. He X: Unwinding a path to nuclear beta-catenin. Cell 2006, 127:40-42.
87. Wang H, Gao X, Yang JJ, Liu ZR: Interaction between p68 RNA helicase and Ca2 + -calmodulin promotes cell migration and metastasis. Nat Commun 2013, 4:1354.
88. Le Dily F, Metivier R, Gueguen MM, Le Peron C, Flouriot G, Tas P, Pakdel F: COUP-TFI modulates estrogen signaling and influences proliferation, survival and migration of breast cancer cells. Breast Cancer Res Treat 2008, 110:69-83.
89. Mi J, Liu Y, Rabbani ZN, Yang Z, Urban JH, Sullenger BA, Clary BM: In vivo selection of tumor-targeting RNA motifs. Nat Chem Biol 2010, 6:22-24.
90. Jiang GM, Wang HS, Zhang F, Zhang KS, Liu ZC, Fang R, Wang H, Cai SH, Du J: Histone deacetylase inhibitor induction of epithelial-mesenchymal transitions via up-regulation of Snail facilitates cancer progression. Biochim Biophys Acta 1833, 2013:663-671.
91. Carter CL, Lin C, Liu CY, Yang L, Liu ZR: Phosphorylated p68 RNA helicase activates Snail1 transcription by promoting HDAC1 dissociation from the Snail1 promoter. Oncogene 2010, 29:5427-5436.
92. Peinado H, Ballestar E, Esteller M, Cano A: Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004, 24:306-319.
93. Tomao F, Papa A, Rossi L, Strudel M, Vici P: Lo Russo G. Tomao S: Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach. J Exp Clin Cancer Res 2013, 32:48.
94. Yang L, Lin C, Liu ZR: Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation. Mol Cancer Res 2005, 3:355-363.
95. Dey H, Liu ZR: Phosphorylation of p68 RNA helicase by p38 MAP kinase contributes to colon cancer cells apoptosis induced by oxaliplatin. BMC Cell Biol 2012, 13:27.
96. Yang L, Lin C, Sun SY, Zhao S, Liu ZR: A double tyrosine phosphorylation of P68 RNA helicase confers resistance to TRAIL-induced apoptosis. Oncogene 2007, 26:6082-6092.